Fujian Aonong Biological Technology Group Incorporation Limited (603363.SS)
CNY 3.79
(-1.56%)
CNY 3.79
(-1.56%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 1.32 Billion CNY | -59.62% |
| 2022 | 3.28 Billion CNY | 27.03% |
| 2021 | 2.58 Billion CNY | 49.57% |
| 2020 | 1.73 Billion CNY | 188.82% |
| 2019 | 599.27 Million CNY | 38.35% |
| 2018 | 433.15 Million CNY | 10.48% |
| 2017 | 392.05 Million CNY | 37.43% |
| 2016 | 285.27 Million CNY | 17.55% |
| 2015 | 242.67 Million CNY | 0.1% |
| 2014 | 242.41 Million CNY | 3.84% |
| 2013 | 233.44 Million CNY | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | 891.81 Million CNY | -10.16% |
| 2024 Q1 | 992.62 Million CNY | -25.26% |
| 2024 Q3 | 801.41 Million CNY | -10.14% |
| 2023 Q4 | 1.32 Billion CNY | -47.66% |
| 2023 Q2 | 2.84 Billion CNY | -18.3% |
| 2023 Q1 | 3.48 Billion CNY | 5.89% |
| 2023 FY | 1.32 Billion CNY | -59.62% |
| 2023 Q3 | 2.53 Billion CNY | -10.8% |
| 2022 Q1 | 2.94 Billion CNY | 13.7% |
| 2022 FY | 3.28 Billion CNY | 27.03% |
| 2022 Q4 | 3.28 Billion CNY | 7.24% |
| 2022 Q2 | 2.96 Billion CNY | 0.74% |
| 2022 Q3 | 3.06 Billion CNY | 3.42% |
| 2021 Q2 | 2.46 Billion CNY | 4.25% |
| 2021 Q3 | 2.85 Billion CNY | 16.08% |
| 2021 Q4 | 2.58 Billion CNY | -9.38% |
| 2021 FY | 2.58 Billion CNY | 49.57% |
| 2021 Q1 | 2.36 Billion CNY | 36.39% |
| 2020 Q2 | 922.52 Million CNY | 22.05% |
| 2020 Q4 | 1.73 Billion CNY | 20.27% |
| 2020 Q3 | 1.43 Billion CNY | 55.99% |
| 2020 FY | 1.73 Billion CNY | 188.82% |
| 2020 Q1 | 755.86 Million CNY | 26.13% |
| 2019 Q4 | 599.27 Million CNY | 19.33% |
| 2019 FY | 599.27 Million CNY | 38.35% |
| 2019 Q2 | 522.46 Million CNY | 16.5% |
| 2019 Q3 | 502.2 Million CNY | -3.88% |
| 2019 Q1 | 448.48 Million CNY | 3.54% |
| 2018 Q2 | 345.44 Million CNY | -20.96% |
| 2018 FY | 433.15 Million CNY | 10.48% |
| 2018 Q4 | 433.15 Million CNY | 10.2% |
| 2018 Q3 | 393.05 Million CNY | 13.78% |
| 2018 Q1 | 437.05 Million CNY | 11.48% |
| 2017 FY | 392.05 Million CNY | 37.43% |
| 2017 Q1 | - CNY | -100.0% |
| 2017 Q2 | 234.15 Million CNY | 0.0% |
| 2017 Q3 | 295.02 Million CNY | 25.99% |
| 2017 Q4 | 392.05 Million CNY | 32.89% |
| 2016 Q4 | 285.27 Million CNY | 0.0% |
| 2016 FY | 285.27 Million CNY | 17.55% |
| 2015 FY | 242.67 Million CNY | 0.1% |
| 2014 FY | 242.41 Million CNY | 3.84% |
| 2013 FY | 233.44 Million CNY | 0.0% |